NPO ASrid

Astrid Pharma has developed BioCapZ, a multifunctional protein-based nano capsid platform capable of encapsulating diverse therapeutic and diagnostic agents—including DNA, RNA, proteins, and gene editors like CRISPR—for targeted delivery via various routes. The system offers high tissue tropism, mucosal stability for potential oral administration, non-infectious safety profile with low toxicity, no refrigeration requirement for storage/transportation, and modular/personalized functionalization. The company focuses on partnerships/licensing to generate revenue while developing internal applications. There are no published clinical results.